PfeIF4E and PfeIF4A colocalize and their double-stranded RNA inhibits Plasmodium falciparum proliferation

Area of Science:

• Molecular parasitology
• Biochemistry
• Bioinformatics

Background:

• The translation initiation complex eIF4F is crucial for protein synthesis in eukaryotes.
• Components of eIF4F, including eukaryotic initiation factor 4A (eIF4A), eukaryotic initiation factor 4E (eIF4E), eukaryotic initiation factor 4G (eIF4G), and poly (A) binding protein (PABP), are conserved in the malaria parasite Plasmodium falciparum.
• Previous studies confirmed the structural and functional conservation of these components in P. falciparum.

Purpose of the Study:

• To further characterize Plasmodium falciparum eukaryotic initiation factor 4A (PfeIF4A) and Plasmodium falciparum eukaryotic initiation factor 4E (PfeIF4E).
• To investigate the localization and functional interaction of PfeIF4A and PfeIF4E.
• To assess the therapeutic potential of inhibiting PfeIF4A and PfeIF4E for malaria treatment.

Main Methods:

• Bioinformatics and biochemical analyses were employed for characterization.
• Co-localization studies were performed to determine the subcellular localization of PfeIF4A and PfeIF4E.
• Double-stranded RNA (dsRNA) targeting PfeIF4A and PfeIF4E was used to assess growth inhibition in parasite cultures.

Main Results:

• PfeIF4A and PfeIF4E were found to be co-localized.
• Both proteins predominantly localize to the cytoplasm of the parasite.
• Co-addition of PfeIF4A and PfeIF4E dsRNA resulted in approximately 67% growth inhibition of P. falciparum cultures.
• Inhibition of both factors simultaneously proved more effective in hindering parasite proliferation.

Conclusions:

• PfeIF4A and PfeIF4E are critical for the growth and survival of Plasmodium falciparum.
• Simultaneous inhibition of PfeIF4A and PfeIF4E represents a promising strategy for developing new antimalarial therapies.
• Targeting the translation initiation pathway could be a viable approach to combat malaria.